FierceBiotech 2026年1月8日 Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
FierceBiotech 2026年1月8日 Diagonal moves forward with $125M series B round, plots first-in-human study this year
FierceBiotech 2026年1月8日 WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities
FierceBiotech 2026年1月8日 Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
FierceBiotech 2026年1月7日 Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate
FierceBiotech 2026年1月7日 Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
FierceBiotech 2026年1月7日 Staar Surgical's takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
FierceBiotech 2026年1月7日 Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M
FierceBiotech 2026年1月7日 GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push
FierceBiotech 2026年1月6日 Arrowhead takes aim at obesity market with early data on dual gene silencing assets